Viewing Study NCT06390059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-01-28 @ 5:30 AM
Study NCT ID: NCT06390059
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-30
First Post: 2024-02-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: NovoCure Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Ductal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EF-39 View
None PANOVA-4 View
None metastatic pancreatic cancer View
None tumor treating fields View
None atezolizumab View
None gemcitabine and nab-paclitaxel View
None first line treatment View
None mPDAC View